Combination therapy for cancer
CA 2397523 A1 · Owner: Schering Corporation · Inventors: Houghton, Peter J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for treating a human patient afflicted with cancer is provided in , which therapeutically effective amounts of temozolomide and irinotecan are administered to such a patient. Also provided is a medical kit comprising: (a) a supply of temozolomide; (b) a supply of irinotecan; and (c) printed instructions for administering temozolomide and irinotecan to a cancer patient.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 24, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 24, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 24, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.